FDA approves Novo Nordisk's Ozempic to treat chronic kidney disease in those with diabetes, expanding its use – CNBC

Business News

  1. FDA approves Novo Nordisk’s Ozempic to treat chronic kidney disease in those with diabetes, expanding its use  CNBC
  2. US FDA approves Novo Nordisk’s Ozempic to reduce diabetic kidney disease progression  Reuters
  3. Novo Nordisk’s Ozempic Gets FDA Approval as Kidney-Disease Treatment  The Wall Street Journal
  4. F.D.A. Approves Ozempic to Treat Kidney Disease  The New York Times
  5. Ozempic’s FDA Approval Just Sent Shockwaves Through the Kidney Disease Market  Yahoo Finance

Source: Business News

/by